We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
137 hedge funds and large institutions have $375M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 44 increasing their positions, 42 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
125% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 12
13% more capital invested
Capital invested by funds: $331M → $375M (+$44M)
12% more funds holding
Funds holding: 122 → 137 (+15)
5% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 42
23% less call options, than puts
Call options by funds: $3.65M | Put options by funds: $4.76M
Holders
137
Holders Change
+15
Holders Change %
+12.3%
% of All Funds
2.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
44
Reduced
42
Closed
12
Calls
$3.65M
Puts
$4.76M
Net Calls
-$1.1M
Net Calls Change
-$437K
Top Buyers
| 1 |
Citigroup
New York
|
+$4.12M |
| 2 |
Rafferty Asset Management
New York
|
+$2.53M |
| 3 |
BlackRock
New York
|
+$2.3M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.83M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.8M |
